Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
Rhea-AI Summary
Assertio Holdings (Nasdaq: ASRT) has scheduled the release of its fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025, after market close. The company will host a live webcast earnings conference call at 4:30 p.m. Eastern Time following the results announcement.
Investors can access the webcast through Assertio's investor relations website, with connection recommended 10 minutes prior to start. For telephone participation, participants should dial +1-646-307-1963 with call ID 3278948. A replay will be available approximately two hours after the call on the company's investor website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ASRT declined 0.89%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAKE FOREST, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.
To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-646-307-1963. The call ID is 3278948.
A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.
About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients through marketing such products for oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
mkreps@darrowir.com
FAQ
When will Assertio Holdings (ASRT) release Q4 and full year 2024 earnings?
How can investors join Assertio's (ASRT) Q4 2024 earnings call?
What time is Assertio Holdings' (ASRT) Q4 2024 earnings conference call?
Where can I find the replay of Assertio's (ASRT) Q4 2024 earnings call?
